According to ImmunityBio's latest financial reports the company's current EPS (TTM) is -$1.53. In 2022 the company made an earnings per share (EPS) of -$1.41 a decrease over its 2021 EPS that were of -$1.19.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.56 | 10.52% |
2022 | -$1.41 | 17.98% |
2021 | -$1.19 | 53.72% |
2020 | -$0.78 |